glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://i.ytimg.com/vi/t6CAAyoH37o/maxresdefault.jpg)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://c.firstwordpharma.com/firstwordgroup/assets/images/obesity_cost_burden.jpeg)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://www.thedailybeast.com/resizer/v2/NWD2ALNTD5CZJMCUW2OJQOQ37M.jpg?smart=true&auth=42b0df8272f402a52be8945e979104af6f2b5891cc365166459b2f7c2214b658&width=1600&height=900)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://static.biospace.com/dims4/default/4dc6217/2147483647/strip/true/crop/905x510+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Ff0%2F25%2F2f8382cb4f718c22b6197571e997%2Fricks-cropped.png)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://images.everydayhealth.com/images/2025/trump-weight-loss-drug-deal-medicare-coverage-lower-prices-1440x810.jpg?w=576)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://eu-images.contentstack.com/v3/assets/bltf2605c1a31475f8b/blt67d6c84ad4a40e28/690e8fad5040160c4fce6707/GettyImages-2196049931-GLP-Resized.jpg?width=1280&auto=webp&quality=80&disable=upscale)
























